Under the terms of this agreement, Virbac will divest a combination of titles and rights for the United States on trademarks, marketing authorizations, patents, know-how, and other assets, related to two parasiticides for dogs​: SENTINEL​^® FLAVOR TABS​^® and SENTINEL​^®  SPECTRUM​^®​. In relation with the transaction, Virbac will keep its commercial structure substantially unchanged, and will continue to manufacture SENTINEL​^® SPECTRUM​^®​ at its Bridgeton, Missouri site for the next ten years. 

Thanks to the ongoing support of The Every Dog Project, Virbac is expanding the initiative to become The Every Pet Project. It will now include all pets, with the intention of making an even bigger impact.

Francois Fournier, CEO of Virbac North America, explained the thinking behind the expansion: 
“The Every Pet Project will help us do more for the communities we serve and enable us to improve the quality of care for pets that need it the most.”

Through The Every Pet Project, Virbac’s goal is to help ensure that EVERY PET, EVERYWHERE enjoys a happy  life and is able to receive the care and protection they deserve. By engaging with clinics, pet owners, and various organizations, Virbac is striving to raise awareness about the project, help as many charities as possible, and draw attention to the unmet medical needs facing pets today. 

WESTLAKE, TX, APRIL 9, 2020 — Virbac Corporation has announced the availability of EASOTIC (hydrocortisone aceponate, miconazole nitrate, gentamicin sulfate) Otic Suspension for Dogs, a prescription treatment for canine otitis externa.

Virbac announces François Fournier’s appointment as President & CEO of Virbac North America, effective January 7, 2019. His main mission is to lead and develop all North American Virbac activities, in line with the Virbac Group’s global strategy.

Virbac Corporation has announced the launch of C.E.T.^® VEGGIEDENT^® FR3SH^® Tartar Control Chews for Dogs, which uniquely targets bad breath while supporting proper digestion.